Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=41189993
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Comparing the efficacy of different types of exercise therapy in patients with
essential hypertension: a systematic review and network meta-analysis
#MMPMID41189993
Liu L
; Wang J
; Ji X
; Wang A
; Yang S
; Chi X
; Hu L
; Zhang B
; Ma L
Front Cardiovasc Med
2025[]; 12
(?): 1604112
PMID41189993
show ga
OBJECTIVE: To compare the efficacy of different types of exercise modalities such
as Tai Chi, Baduanjin, and Aerobic exercise in the treatment of hypertension.
METHODS: This article retrieved randomized controlled trials (RCTs) from the
establishment of databases such as CNKI, WanFang, VIP, CBM, PubMed, Embase, Web
of Science, and Cochrane Library to December 9, 2024. After assessing the risk of
bias using the Cochrane risk of bias tool, a network meta-analysis was performed
using Rev Man 5.4 and Stata 15 software. The primary outcome indicator of this
article is Ambulatory Blood Pressure Measurement (ABPM), which includes 24-h
average systolic blood pressure (SBP) and 24-h average diastolic blood pressure
(DBP). RESULTS: A total of 63 RCTs meeting the criteria were included, involving
5,663 patients. The network meta-analysis results showed that compared with the
control group, Light-intensity continuous training (LIAE)+antihypertensive
medication [WMD?=?-1.82, 95%CI(-2.93, -0.71)] was the most effective intervention
for lowering SBP. For lowering DBP, Wuqinxi?+?antihypertensive medication
[WMD?=?-2.78, 95% CI (-4.1,-1.45)] was the most effective intervention. And the
differences were statistically significant (P?0.05). CONCLUSION: Exercise
therapy combined with antihypertensive drugs may achieve a more significant blood
pressure-lowering effect, and LICT, Wuqinxi, and Liuzijue may be higher priority
options. SYSTEMATIC REVIEW REGISTRATION: http://wwwcrdyork.ac.uk/PROSPERO/,
PROSPERO CRD42024626332.